CSB 2.012 Note Paragraph (d) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read:

CSB 2.012 Note (d) Phentermine

CSB 2.012 History History: Cr. Register, August, 1976, No. 248, eff. 9-1-76.

CSB 2.012 Note CSB 2.13 Addition of dextropropoxyphene to schedule IV. Subsection (4), s. 161.20, Stats., schedule IV is hereby created to read:

CSB 2.012 Note (4) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:

CSB 2.012 Note (a) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane)

CSB 2.012 Note Note: See Chapter 206, Laws of 1981 section 51.

CSB 2.012 History History: Cr. Register, November, 1977, No. 263, eff. 12-1-77.

CSB 2.012 Note CSB 2.14 Addition of prazepam to schedule IV. Paragraph (km), sub. (2), s. 161.20, Stats., schedule IV is hereby created to read:

CSB 2.012 Note (km) Prazepam

CSB 2.012 History History: Cr. Register, November, 1977, No. 263, eff. 12-1-77.

CSB 2.012 Note CSB 2.15 Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV. (1) Paragraph (mn) of sub. (4), s. 161.14, Stats., is created to read:

CSB 2.012 Note (mn) Parahexyl

CSB 2.012 Note (2) Paragraph (a) of sub. (3), s. 161.22, Stats., is repealed.

CSB 2.012 Note (3) Paragraph (nm) of sub. (2), s. 161.20, Stats., is created to read:

CSB 2.012 Note (nm) Triazolam

CSB 2.012 History History: Cr. Register, October, 1984, No. 346, eff. 11-1-84.

CSB 2.012 Note CSB 2.16 Transfer of sufentanil from schedule I to schedule II. (1) Section 161.14 (2) (xg), Stats., is repealed.

CSB 2.012 Note (2) Section 161.16 (3) (y), Stats., is created to read:

CSB 2.012 Note (y) Sufentanil

CSB 2.012 History History: Cr. Register, October, 1984, No. 346, eff. 11-1-84.

CSB 2.012 Note CSB 2.17 Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II. (2) Paragraph (b) of s. 161.14 (5), Stats., is adopted to read:

CSB 2.012 Note (b) Methaqualone

CSB 2.012 Note (3) Subsection (7) (am) of s. 161.16, Stats., is repealed.

CSB 2.012 Note (4) Subsection (10) (a) of s. 161.16, Stats., is created to read:

CSB 2.012 Note (10) Hallucinogenic substances. (a) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. food and drug administration approved drug product. (Other names for dronabinol are (6a R - trans) - 6a, 7, 8, 10a - tetrahydro - 6, 6, 9 - trimethyl - 3 -pentyl-6H-dibenzo (b, d) pyran - 1 - ol, or (-) - delta - 9 - (trans) - tetrahydrocannabinol.)

CSB 2.012 History History: Cr. Register, August, 1986, No. 368, eff. 9-1-86; CR 03-056: r. (1) Register January 2004 No. 577, eff. 2-1-04.

CSB 2.012 Note CSB 2.18 Addition of 3,4-methylenedioxymethamphetamine to schedule I. Paragraph (am) of s. 161.14 (4), Stats., is created to read:

CSB 2.012 Note (am) 3, 4-methylenedioxymethamphetamine, commonly known as“MDMA”;